Search research articles
Contact Us
Filters
Showing results (211-220 of 252) with videos related to
Page
of 26
Sort By:
Antibody Therapeutics
|
October 17, 2023
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
Song Li, Dianze Chen, Huiqin Guo, et al.
Journal of Hematology & Oncology
|
March 3, 2018
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
Lanping Xu, Hu Chen, Jing Chen, et al.
Leukemia & Lymphoma
|
June 13, 2022
Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome
Xiaodong Lyu, Tao Li, Dandan Zhu, et al.
Biomarker Research
|
March 2, 2021
Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
Rongqun Guo, Mengdie Lü, Fujiao Cao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 25, 2015
Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China
Junru Liu, He Huang, Yan Li, et al.
Chinese Medical Journal
|
July 8, 2025
Decoding the immune microenvironment of secondary chronic myelomonocytic leukemia due to diffuse large B-cell lymphoma with CD19 CAR-T failure by single-cell RNA-sequencing
Xudong Li, Hong Huang, Fang Wang, et al.
American Journal of Hematology
|
May 30, 2026
Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma
Shenrui Bai, Yongping Song, Liang Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 25, 2024
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
Binglei Zhang, Jianxiang Shi, Xiaojing Shi, et al.
International Journal of Cancer
|
February 20, 2021
miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition
Pu Xiang, Yiu To Yeung, Jiheng Wang, et al.
Transfusion
|
December 15, 2017
Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study
Jun Zhu, Huiqiang Huang, Huan Chen, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 252) with videos related to
Sort By:
Page
of 26
Antibody Therapeutics
|
October 17, 2023
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
Song Li, Dianze Chen, Huiqin Guo, et al.
Journal of Hematology & Oncology
|
March 3, 2018
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
Lanping Xu, Hu Chen, Jing Chen, et al.
Leukemia & Lymphoma
|
June 13, 2022
Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome
Xiaodong Lyu, Tao Li, Dandan Zhu, et al.
Biomarker Research
|
March 2, 2021
Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
Rongqun Guo, Mengdie Lü, Fujiao Cao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 25, 2015
Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China
Junru Liu, He Huang, Yan Li, et al.
Chinese Medical Journal
|
July 8, 2025
Decoding the immune microenvironment of secondary chronic myelomonocytic leukemia due to diffuse large B-cell lymphoma with CD19 CAR-T failure by single-cell RNA-sequencing
Xudong Li, Hong Huang, Fang Wang, et al.
American Journal of Hematology
|
May 30, 2026
Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma
Shenrui Bai, Yongping Song, Liang Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 25, 2024
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
Binglei Zhang, Jianxiang Shi, Xiaojing Shi, et al.
International Journal of Cancer
|
February 20, 2021
miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition
Pu Xiang, Yiu To Yeung, Jiheng Wang, et al.
Transfusion
|
December 15, 2017
Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study
Jun Zhu, Huiqiang Huang, Huan Chen, et al.
Page
of 26